Literature DB >> 22235789

Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus.

Alessandra Pontillo1, Martina Girardelli, Anselmo J Kamada, Joao A T Pancotto, Eduardo A Donadi, Sergio Crovella, Paula Sandrin-Garcia.   

Abstract

Recent findings provide evidence of inflammasome critical role in the predisposition to autoimmune disorders. The involvement of inflammasome in the pathogenesis of systemic lupus erythematosus (SLE) has been hypothesized even if no significant association within inflammasome genes mutations or polymorphisms and lupus has been reported yet. We analyzed 14 single nucleotide polymorphisms (SNPs) within 7 inflammasome genes (NLRP1, NLRP3, NLRC4, AIM2, CARD8, CASP1, IL1B) in 144 patients affected by systemic lupus erythematosus and in 158 healthy controls from Southern Brazilian (state of São Paulo) with the aim of disclosing the possible role of inflammasome genes in the susceptibility of SLE. Our results demonstrated that NLRP1 rs2670660 SNP and the NLRP1 rs12150220-rs2670660 A-G haplotype were associated with SLE in our study population, and in particular with the development of nephritis, rash and arthritis. These findings are concordant with previously reported association of NLRP1 with vitiligo and type-1 diabetes underlining once more the involvement of NALP1 inflammasome in the pathogenesis of autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22235789     DOI: 10.3109/08916934.2011.637532

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  63 in total

1.  Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity.

Authors:  Joshua N Finger; John D Lich; Lauren C Dare; Michael N Cook; Kristin K Brown; Chaya Duraiswami; John Bertin; John J Bertin; Peter J Gough
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

Review 2.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

3.  Cross talk between neuroregulatory molecule and monocyte: nerve growth factor activates the inflammasome.

Authors:  Ananya Datta-Mitra; Smriti Kundu-Raychaudhuri; Anupam Mitra; Siba P Raychaudhuri
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 4.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

5.  Advances in Disease Mechanisms and Translational Technologies: Clinicopathologic Significance of Inflammasome Activation in Autoimmune Diseases.

Authors:  J Michelle Kahlenberg; Insoo Kang
Journal:  Arthritis Rheumatol       Date:  2020-01-15       Impact factor: 10.995

6.  NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome.

Authors:  Cecilia B Levandowski; Christina M Mailloux; Tracey M Ferrara; Katherine Gowan; Songtao Ben; Ying Jin; Kimberly K McFann; Paulene J Holland; Pamela R Fain; Charles A Dinarello; Richard A Spritz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 7.  Clinical guidelines and definitions of autoinflammatory diseases: contrasts and comparisons with autoimmunity-a comprehensive review.

Authors:  M Zen; M Gatto; M Domeneghetti; L Palma; E Borella; L Iaccarino; L Punzi; A Doria
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

8.  Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1.

Authors:  Jianhua Liu; Celine C Berthier; J Michelle Kahlenberg
Journal:  Arthritis Rheumatol       Date:  2017-08-08       Impact factor: 10.995

9.  Differential expression of inflammasomes in lung cancer cell lines and tissues.

Authors:  Hui Kong; Yanli Wang; Xiaoning Zeng; Zailiang Wang; Hong Wang; Weiping Xie
Journal:  Tumour Biol       Date:  2015-04-25

Review 10.  The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?

Authors:  J Michelle Kahlenberg; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.